The CAR itself, containing a human germline antibody 3-23/B3-derived scFv is inert on its own but paired with AM targeting PSMA or TMEFF2 (tomoregulin-2) it enabled dose-dependent tumour lysis and cytokine secretion. The gene discussed is FOLH1; the disease is neoplasm.